News about Oklo

This article compares next-generation nuclear developers Oklo (OKLO) and X-Energy (XE) after their recent sell-offs. Oklo develops Aurora microreactors rated at 15 MWe to 75 MWe and expects to start deploying its first commercial reactors in 2027, with revenue projected to rise from less than $3 million in 2026 to $51 million in 2028. X-Energy sells Xe-100 small modular reactors, plans its first deployments in the early 2030s, and is projected to grow revenue from $212 million to $1.2 billion over 2026–2028. The author notes Oklo's $5.1 billion market cap equals 100 times its 2028 sales, versus 2.5 times for X-Energy's $3.0 billion market cap, and suggests X-Energy appears undervalued relative to its growth potential.

Barclays downgraded NuScale Power (SMR) from Equal Weight to Underweight and cut its price target below the last close. In morning trading, the stock fell 7% to $5.26, a new 52-week low, while Oklo fell 5% and Centrus Energy dropped 3%. UBS had cut the stock to Sell in September over long commercialization timelines, weak customer commitments and heavy expected cash burn. The core issue is that NuScale has yet to land a binding reactor order, despite holding the only U.S. NRC design certification for a small modular reactor, while ENTRA1 Energy is in talks with the Tennessee Valley Authority toward a definitive power purchase agreement. The article flags TVA updates and upcoming earnings as the key catalysts to watch.